Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy-Reference-Cited by-同舟云学术

Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy

Published:2019-04-04 Issue:5 Volume:39 Page:553-563
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Toh Yi Long¹^ORCID,Shariq Mujtaba Juliana¹,Bansal Sumit¹,Yeo Angie¹,Shwe Maung¹²,Lau Aik Jiang¹³,Chan Alexandre¹²⁴

Affiliation:

1. Department of Pharmacy Faculty of Science National University of Singapore Singapore

2. Department of Pharmacy National Cancer Centre Singapore Singapore

3. Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore

4. Oncology Academic Clinical Program Duke‐National University of Singapore Medical School Singapore

Funder

National Medical Research Council

National University of Singapore

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2259

Reference48 articles.

1. Cognitive Changes in Cancer Survivors

2. Prevalence, mechanisms, and management of cancer-related cognitive impairment

3. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

4. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer

5. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review;Journal of Cancer Research and Clinical Oncology;2023-07-11

2. Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care;Research in Clinical Pharmacy;2023-06-30

3. Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital Cancers;International Journal of Behavioral Medicine;2022-12-02

4. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review;Critical Reviews in Oncology/Hematology;2022-12

5. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy;Scientific Reports;2022-10-03